US patent office issued notification to grant patent to Stempeutics for its stem cell drug…
Stempeucel is derived from allogeneic pooled mesenchymal stromal cells extracted from the bone marrow of healthy, adult voluntary…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Stempeutics
Stempeutics partners with Kemwell for global development and commercialisation of stem cell…
Under the agreement, Kemwell will take a minority stake in Stempeutics and invest up to Rs 950 million
DCGI gives limited approval to market Stempeutics’ allogeneic cell therapy
Stempeucel is used in the treatment of Buerger’s disease
Cipla launches anti-ageing skin care product Cutisera
Cutisera has been developed by Stempeutics
Cipla has launched a novel “5 in 1” anti-ageing skin care product Cutisera developed…
Stempeutics receives Japan process patent for its stem cell drug ‘Stempeucel’
Stempeucel is derived from allogeneic pooled mesenchymal stromal cells extracted from the bone marrow of healthy, adult voluntary…